|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
CMV Qual by PCR 10601
Test CodeCMVPCR
Alias/See Also
CMVPCR
CPT Codes
87496
Preferred Specimen
1 mL whole blood collected in an EDTA (lavender-top) tube or
1 mL plasma collected in an EDTA (lavender-top), or PPT EDTA (white-top) tube or
1 mL serum or
1 mL CSF, bronchoalveolar lavage, amniotic fluid amniotic fluid supernatant, random urine collected in a sterile leak-proof container or
0.5 mL vitreous (eye) fluid collected in a sterile leak-proof container
1 mL plasma collected in an EDTA (lavender-top), or PPT EDTA (white-top) tube or
1 mL serum or
1 mL CSF, bronchoalveolar lavage, amniotic fluid amniotic fluid supernatant, random urine collected in a sterile leak-proof container or
0.5 mL vitreous (eye) fluid collected in a sterile leak-proof container
Minimum Volume
1
Other Acceptable Specimens
3 cubic mm fresh (unfixed) tissue collected in a sterile plastic leak-proof container
Instructions
Collect one lavender (EDTA) Send plasma refrigerated. Serum, CSF, Amniotic Fluid, urine, or bronchoaveolar lavage: collect in a sterile, leakproof container labeled with the type of specimen, and transport refrigerated.
Transport Container
LAV
Transport Temperature
R
Specimen Stability
Whole blood
Room temperature: 48 hours
Refrigerated: 8 days
Frozen: Unacceptable
All other sample types
Room temperature: 48 hours
Refrigerated: 8 days
Frozen: 30 days
Room temperature: 48 hours
Refrigerated: 8 days
Frozen: Unacceptable
All other sample types
Room temperature: 48 hours
Refrigerated: 8 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Heparinized specimens • Unspun PPT tube • Paraffin embedded (FFPE) tissue
Methodology
Real-Time Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 1-3 days
Reference Range
Not detected
Clinical Significance
In patients who are immunocompromised, CMV may cause disseminated, severe disease. CMV is also the most common cause of congenital viral infection in humans. Quantitative PCR methods may be useful in monitoring CMV replication in immunosuppressed patients or in determining the viral load of CMV in amniotic fluid.
Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153
